Overview
- CNN reports the agency is preparing its strongest label warning for Covid-19 shots, with a final decision not yet made.
- Officials have not settled whether a boxed warning would cover all vaccines or only mRNA products or which age groups it would address, with timing targeted for year-end.
- The effort is reportedly led by FDA chief medical and scientific officer Vinay Prasad, whose November memo cited at least 10 pediatric deaths from heart inflammation as probably vaccine-related.
- HHS says the FDA has widened a safety review to examine deaths across age groups, building on existing labels that already note rare myocarditis and pericarditis risks.
- Public-health groups warn that a boxed warning without released case-level data could undermine trust, as Trump administration health officials have already scaled back recommendations for healthy children and pregnant women.